RFK Jr. ends Emergency Use Authorizations for COVID-19 drugs
Source: SeekingAlpha
2026-06-30 14:30:14 ET
More on Pfizer, Merck
- Pfizer: Why Being Bullish Makes Sense Despite The Patent Cliff
- Antibody-Drug Conjugates: Not Quite Worked Out Yet
- Merck's Oncology Engine Is Still Accelerating
- FDA commissioner contenders down to three - report
- Record-setting healthcare M&A activity to extend through H2: PwC
Read the full article on Seeking Alpha
For further details see:
RFK Jr. ends Emergency Use Authorizations for COVID-19 drugs
BioNTech SE
NASDAQ: BNTX
BNTX Trading
-0.2% G/L:
$91.82 Last:
478,082 Volume:
$91.79 Open:
BNTX Latest News
June 25, 2026 10:57:22 am
The New Cancer Moonshot: Innovative Companies Pursuing Game-Changing Therapies
$26,377,590,776
95,508,380
N/A
104
N/A
Biotechnology & Life Sciences
Healthcare
DE
Mainz
